What is Staar Surgical's SG&A?

Staar Surgical (STAA) reported SG&A of $60.88M in Q1 2026.

How has Staar Surgical's SG&A changed year-over-year?

Staar Surgical's SG&A decreased by 28.7% year-over-year, from $85.41M to $60.88M.

What is the long-term trend for Staar Surgical's SG&A?

Over 4 years (2021 to 2025), Staar Surgical's SG&A has grown at a 17.2% compound annual growth rate (CAGR), from $145.3M to $274.13M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Staar Surgical STAA SG&A

SG&A at other companies

Johnson & JohnsonJNJ

$6.03B+18.0%

Bausch Health CompaniesBHC

$861M-0.7%

IAR

Integra LifeSciencesIART

$178.24M-1.8%

ITG

Integer HoldingsITGR

$58.71M+14.8%

GlaukosGKOS

$92.94M+31.5%

HRO

HarrowHROW

$43.23M+6.7%

Other financials

Income statement

See full

Revenue$93.5M+120%

Gross profit$68.9M+146%

Operating income$8.0M+114%

Net income$5.2M+110%

EPS (diluted)$0.10+109%

Balance sheet

See full

Cash & equivalents$131.9M-23.8%

Total debt$37.3M+1.7%

Total equity$352.4M+0.7%

Total assets$451.1M-1.4%

Cash flow

See full

Operating cash flow-$21.7M-278%

CapEx$443.0K-69.8%

Free cash flow-$22.1M-207%

Valuation

See full

Market cap$1.44B+77.9%

Enterprise value$1.35B+100.0%

P/S5×+2.1×

Profitability

See full

Gross margin76.9%+2.9pp

Operating margin-9.1%-3.5pp

Net margin-7.2%-3.0pp

FCF margin-19.6%+55.9pp

Returns & leverage

See full

Return on equity-6%-2.4pp

Debt / equity0.1×0.0×

Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Staar Surgical's SG&A?: Staar Surgical (STAA) reported SG&A of $60.88M in Q1 2026.
How has Staar Surgical's SG&A changed year-over-year?: Staar Surgical's SG&A decreased by 28.7% year-over-year, from $85.41M to $60.88M.
What is the long-term trend for Staar Surgical's SG&A?: Over 4 years (2021 to 2025), Staar Surgical's SG&A has grown at a 17.2% compound annual growth rate (CAGR), from $145.3M to $274.13M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.